Literature DB >> 17079310

Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3.

Pushpa Jayaraman1, Tuofu Zhu, Lynda Misher, Deepika Mohan, LaRene Kuller, Patricia Polacino, Barbra A Richardson, Helle Bielefeldt-Ohmann, David Anderson, Shiu-Lok Hu, Nancy L Haigwood.   

Abstract

To model human immunodeficiency virus (HIV) perinatal transmission, we studied infection of simian-human immunodeficiency virus (SHIV) SF162P3 in 10 pregnant Macaca nemestrina females and their offspring. Four of nine infants born to and suckled by these dams had evidence of infection, a transmission rate of 44.4% (95% confidence interval, 13.7% to 78.8%). We quantified transplacentally acquired and de novo Env-specific immunoglobulin G (IgG), IgM, and neutralizing antibodies in newborns. Transmission of escape variants was confirmed. In utero infection (n = 1) resulted in high viremia, depletion of peripheral CD4+ T cells, and rapid evolution of env in blood and tissues. Peripartum or postpartum SHIV infection (n = 3) resulted in postacute viral control that was undetectable by very sensitive multiplex PCR, despite increasing antibodies. Seropositive infants with highly controlled viremia had homogeneous peripheral blood env sequences, and their tissues had <3 copies per million cells. A high incidence of seropositive virus-low or -negative SHIV infection in infant macaques has implications for HIV type 1 perinatal transmission and detection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079310      PMCID: PMC1797486          DOI: 10.1128/JVI.01759-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Selection forces and constraints on retroviral sequence variation.

Authors:  J Overbaugh; C R Bangham
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

2.  HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

Authors:  M Hermankova; S C Ray; C Ruff; M Powell-Davis; R Ingersoll; R T D'Aquila; T C Quinn; J D Siliciano; R F Siliciano; D Persaud
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.

Authors:  D N Forthal; G Landucci; E S Daar
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

Authors:  R Kaul; F A Plummer; J Kimani; T Dong; P Kiama; T Rostron; E Njagi; K S MacDonald; J J Bwayo; A J McMichael; S L Rowland-Jones
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.

Authors:  K K Van Rompay; M B McChesney; N L Aguirre; K A Schmidt; N Bischofberger; M L Marthas
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

6.  Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).

Authors:  J M Harouse; A Gettie; T Eshetu; R C Tan; R Bohm; J Blanchard; G Baskin; C Cheng-Mayer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.

Authors:  K Broliden; J Hinkula; C Devito; P Kiama; J Kimani; D Trabbatoni; J J Bwayo; M Clerici; F Plummer; R Kaul
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

8.  Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.

Authors:  Dan H Barouch; Jennifer Kunstman; Marcelo J Kuroda; Jörn E Schmitz; Sampa Santra; Fred W Peyerl; Georgia R Krivulka; Kristin Beaudry; Michelle A Lifton; Darci A Gorgone; David C Montefiori; Mark G Lewis; Steven M Wolinsky; Norman L Letvin
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

9.  Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.

Authors:  J L Greenier; C J Miller; D Lu; P J Dailey; F X Lü; K J Kunstman; S M Wolinsky; M L Marthas
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques.

Authors:  M L Marthas; K K van Rompay; M Otsyula; C J Miller; D R Canfield; N C Pedersen; M B McChesney
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more
  19 in total

1.  Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers.

Authors:  Madhumita Mahalanabis; Pushpa Jayaraman; Toshiyuki Miura; Florencia Pereyra; E Michael Chester; Barbra Richardson; Bruce Walker; Nancy L Haigwood
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

2.  Neuro-invasion by a 'Trojan Horse' strategy and vasculopathy during intrauterine flavivirus infection.

Authors:  Helle Bielefeldt-Ohmann; Natalia P Smirnova; Airn-Elizabeth Tolnay; Brett T Webb; Alfredo Q Antoniazzi; Hana van Campen; Thomas R Hansen
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

3.  Macaque homologs of Kaposi's sarcoma-associated herpesvirus (KSHV) infect germinal center lymphoid cells, epithelial cells in skin and gastrointestinal tract and gonadal germ cells in naturally infected macaques.

Authors:  Helle Bielefeldt-Ohmann; A Gregory Bruce; Kellie Howard; Minako Ikoma; Margaret E Thouless; Timothy M Rose
Journal:  Virology       Date:  2018-04-22       Impact factor: 3.616

4.  Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.

Authors:  Egidio Brocca-Cofano; Cuiling Xu; Katherine S Wetzel; Mackenzie L Cottrell; Benjamin B Policicchio; Kevin D Raehtz; Dongzhu Ma; Tammy Dunsmore; George S Haret-Richter; Karam Musaitif; Brandon F Keele; Angela D Kashuba; Ronald G Collman; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 5.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

Authors:  Kristina Abel
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

6.  Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques.

Authors:  Cherie T Ng; J Pablo Jaworski; Pushpa Jayaraman; William F Sutton; Patrick Delio; LaRene Kuller; David Anderson; Gary Landucci; Barbra A Richardson; Dennis R Burton; Donald N Forthal; Nancy L Haigwood
Journal:  Nat Med       Date:  2010-10-03       Impact factor: 53.440

7.  The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses.

Authors:  Xiaohong Kong; John T West; Hong Zhang; Danielle M Shea; Tendai J M'soka; Charles Wood
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

Review 8.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

9.  Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection.

Authors:  Maxwel M Omenda; Caitlin Milligan; Katherine Odem-Davis; Ruth Nduati; Barbra A Richardson; John Lynch; Grace John-Stewart; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

Review 10.  Four decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center.

Authors:  Thomas M Burbacher; Kimberly S Grant; Julie Worlein; James Ha; Eliza Curnow; Sandra Juul; Gene P Sackett
Journal:  Am J Primatol       Date:  2013-07-19       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.